Literature DB >> 27103775

Cognition, Depressive Symptoms and Vascular Factors among Southwest Tribal Elders.

Francine Gachupin1, Michael D Romero1, Willa J Ortega1, Rita Jojola2, Hugh Hendrie3, Eddie Paul Sr Torres4, Frank Lujan5, Michael Lente5, Barbara Sanchez5, Verna Teller5, Fernando Beita5, Ulysses Abeita5, Beatrice Lente5, Deborah Ruth Gustafson6.   

Abstract

OBJECTIVE: Few data exist on cognitive and depressive symptoms and vascular factors in American Indian (AI) elders. Since vascular risk factors increase risk for cognitive impairments, depression and dementia, and since AI elders are at high vascular risk, it is timely to assess the interplay of these factors in comprehensive studies of aging in this population. To begin, pilot studies must be conducted to show these types of data can be collected successfully.
DESIGN: A cross-sectional pilot study, the Southwest Heart Mind Study (SHMS).
SETTING: Tribal community in the Southwest United States. PARTICIPANTS: AI elders, aged ≥55 years. MAIN OUTCOME MEASURES: Cross-cultural demographic, social network and risk factor surveys; tests of cognition, depression and anxiety; physical measurements; blood biochemistries; and APOE genotyping.
RESULTS: SHMS elders were comparable to other rural elder populations on cognitive and depressive symptom scores. The average CogScore was 28.8 (out of 32), the average Geriatric Depression Scale (GDS) was 6.7 (of 30), and the average Hamilton Anxiety Scale was 1.2 (of 4). 32% possessed at least one APOEe4 allele. High vascular risk was evident: 76% were overweight or obese; 54% self-reported history of hypertension; 24% heart trouble; 32% type 2 diabetes; 35% depression; and 24% a family history of serious memory loss. More than 70% reported prescription medication use. 54% cared for someone besides self.
CONCLUSIONS: A better understanding of the burden of vascular risk in relation to cognition and depression among Southwest Tribes is needed.

Entities:  

Keywords:  American Indian; Cognition; Depression; Vascular

Mesh:

Year:  2016        PMID: 27103775      PMCID: PMC4836905          DOI: 10.18865/ed.26.2.235

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  21 in total

1.  Vascular biomarkers in the prediction of clinical cardiovascular disease: the Strong Heart Study.

Authors:  Mary J Roman; Jorge R Kizer; Lyle G Best; Elisa T Lee; Barbara V Howard; Nawar M Shara; Richard B Devereux
Journal:  Hypertension       Date:  2011-11-07       Impact factor: 10.190

2.  Predictors of performance on the MMSE and the DRS-2 among American Indian elders.

Authors:  Lori L Jervis; Alexandra Fickenscher; Janette Beals; C Munro Cullum; Douglas K Novins; Spero M Manson; David B Arciniegas
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

3.  Mental health disorders among an invisible minority: depression and dementia among american Indian and alaska native elders.

Authors:  Mario D Garrett; Dave Baldridge; William Benson; Jolie Crowder; Nancy Aldrich
Journal:  Gerontologist       Date:  2015-02-15

4.  Lessons learned from international comparative crosscultural studies on dementia.

Authors:  Hugh C Hendrie
Journal:  Am J Geriatr Psychiatry       Date:  2006-06       Impact factor: 4.105

Review 5.  Adipokines: a link between obesity and dementia?

Authors:  Amanda J Kiliaan; Ilse A C Arnoldussen; Deborah R Gustafson
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

6.  Cognitive test performance in a community-based nondemented elderly sample in rural India: the Indo-U.S. Cross-National Dementia Epidemiology Study.

Authors:  M Ganguli; V Chandra; J E Gilby; G Ratcliff; S D Sharma; R Pandav; E C Seaberg; S Belle
Journal:  Int Psychogeriatr       Date:  1996       Impact factor: 3.878

7.  Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures.

Authors:  K Welsh; N Butters; J Hughes; R Mohs; A Heyman
Journal:  Arch Neurol       Date:  1991-03

8.  The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans.

Authors:  S S Richards; C L Emsley; J Roberts; M D Murray; K Hall; S Gao; H C Hendrie
Journal:  J Am Geriatr Soc       Date:  2000-09       Impact factor: 5.562

9.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

10.  Is the risk of Alzheimer's disease and dementia declining?

Authors:  Kenneth M Langa
Journal:  Alzheimers Res Ther       Date:  2015-03-26       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.